Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy - Scorecard - MDSpire
Advertisement
Case Report: Contrast-enhanced ultrasonography for evaluating a newly detected contralateral pulmonary lesion during non-small cell lung cancer chemoimmunotherapy
Clinical Scorecard: Utilizing Contrast-Enhanced Ultrasonography to Assess a Newly Identified Contralateral Pulmonary Lesion in Patients Undergoing Chemoimmunotherapy for Non-Small Cell Lung Cancer
At a Glance
Category
Detail
Condition
Non-Small Cell Lung Cancer (NSCLC)
Key Mechanisms
Contrast-enhanced ultrasonography (CEUS) provides real-time perfusion information to differentiate between malignant and benign pulmonary lesions.
Target Population
Patients undergoing chemoimmunotherapy for NSCLC, particularly those with newly detected pulmonary lesions.
Care Setting
Oncology and pulmonology settings, including inpatient and outpatient evaluations.
Key Highlights
CEUS can aid in the characterization of newly detected pulmonary lesions during treatment.
Real-time perfusion assessment helps differentiate between inflammatory and malignant processes.
Integration of CEUS with clinical and microbiologic data enhances diagnostic accuracy.
Guideline-Based Recommendations
Diagnosis
Use CEUS in conjunction with clinical, laboratory, and imaging data for evaluating new pulmonary lesions.
Management
Consider anti-infective treatment for lesions suspected to be inflammatory based on CEUS findings.
Monitoring & Follow-up
Follow-up with imaging studies, such as CT, to assess lesion regression after treatment.
Risks
Potential misinterpretation of CEUS results if used as a standalone diagnostic tool.
Patient & Prescribing Data
Elderly patients with advanced NSCLC undergoing systemic therapy.
Patients may present with new pulmonary lesions that require careful evaluation to rule out infection or treatment-related changes.
Clinical Best Practices
Utilize CEUS for peripheral pulmonary lesions that are accessible for transthoracic assessment.
Incorporate microbiologic testing when respiratory infections are suspected.
